The platelet P2Y receptors as targets for new antithrombotic drugs.
Cattaneo
M
M
Unit of Hematology and Thrombosis, Department of Surgery, Medicine and Dentistry, Ospedale San Paolo, University of Milan, Via di Rudini 8, 20142 Milan, Italy. marco.cattaneo@unimi.it
D000244:Adenosine Diphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D001792:Blood Platelets / Q000737:chemistry / Q000187:drug effects; D016503:Drug Delivery Systems; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D058919:Purinergic P2 Receptor Antagonists
D005343:Fibrinolytic Agents; C111914:N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D000244:Adenosine Diphosphate